Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sigrun Hallmeyer

2PUBLICATIONS

16CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Nov 08, 2023

Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study.

John M Kirkwood, Lisa A Kottschade, Robert R McWilliams

|Oct 15, 2021

An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma.

Merve Hasanov, Denái R Milton, William H Sharfman

Pageof 1

Frequent Collaborators

1 joint publications

Merve Hasanov

1 joint publications

William H Sharfman

1 joint publications

Bret Taback

1 joint publications

Lee D Cranmer

1 joint publications

Gregory A Daniels

1 joint publications

Mohammed Milhem

1 joint publications

Lynn Feun

1 joint publications

Ralph Hauke

1 joint publications

Gary Doolittle

1 joint publications

Sapna Patel

Frequent Collaborators

1 joint publications

Merve Hasanov

1 joint publications

William H Sharfman

1 joint publications

Bret Taback

1 joint publications

Lee D Cranmer

Top Related Videos

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models

Published on : Sep 06, 2024

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on : Jan 31, 2025

See more related videos

Top Related Videos

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models

Published on : Sep 06, 2024

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on : Jan 31, 2025

See more related videos